1mo ago
inHot take: The FDA fast-tracking that muscular dystrophy treatment is a huge ethical win.
Fast tracking sounds great until you think about the risks they might be skipping. Rushing a treatment can mean missing side effects that show up later, which hurts the very people it's trying to help. Desperate families will say yes to anything, so having a careful process actually protects them. It feels cold, but slowing down to be sure often saves more lives in the long run. Real progress means knowing a treatment is truly safe, not just hoping it is.